User profiles for Stefan Poehlmann
 | Stefan PöhlmannLeiter der Abteilung Infektionsbiologie, Deutsches Primatenzentrum Verified email at mail.de Cited by 47757 |
Alternatives to animal models and their application in the discovery of species susceptibility to SARS-CoV-2 and other respiratory infectious pathogens: A review
…, F Armando, C Rocha, S Poehlmann… - Veterinary …, 2022 - journals.sagepub.com
The emergence of the coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) inspired rapid research efforts targeting the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) inspired rapid research efforts targeting the …
Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
…, G Bernhardt, J Münch, M Hoffmann, S Poehlmann… - medRxiv, 2021 - medrxiv.org
Cerebral venous thrombosis was reported as a rare but serious adverse event in young and
middle-aged vaccinees following immunization with AstraZeneca’s ChAdOx1-nCov-19 …
middle-aged vaccinees following immunization with AstraZeneca’s ChAdOx1-nCov-19 …
Virological traits of the SARS-CoV-2 BA. 2.87. 1 lineage
…, SR Schulz, HM Jaeck, GMN Behrens, S Poehlmann… - bioRxiv, 2024 - biorxiv.org
The highly mutated SARS-CoV-2 BA.2.87.1 lineage was recently detected in South Africa, but
its transmissibility is unknown. Here, we report that BA.2.87.1 efficiently enters human cells …
its transmissibility is unknown. Here, we report that BA.2.87.1 efficiently enters human cells …
Increased lung cell entry of B. 1.617. 2 and evasion of antibodies induced by infection and BNT162b2 vaccination (preprint)
…, HM Jaeck, MV Stankov, GMN Behrens, S Poehlmann… - 2021 - pesquisa.bvsalud.org
The delta variant of SARS-CoV-2, B. 1.617. 2, emerged in India and has subsequently
spread to over 80 countries. B. 1.617. 2 rapidly replaced B. 1.1. 7 as the dominant virus in the …
spread to over 80 countries. B. 1.617. 2 rapidly replaced B. 1.1. 7 as the dominant virus in the …
Therapeutic application of alpha-1-antitrypsin in COVID-19 (preprint)
…, T Volk, PM Lepper, G Danziger, S Poehlmann… - 2021 - pesquisa.bvsalud.org
Rationale The treatment options for COVID-19 patients are sparse and do not show sufficient
efficacy. Alpha-1-antitrypsin (AAT) is a multi-functional host-defense protein with anti-…
efficacy. Alpha-1-antitrypsin (AAT) is a multi-functional host-defense protein with anti-…
SARS-CoV-2 variant B. 1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination (preprint)
…, HM Jaeck, MV Stankov, GMN Behrens, S Poehlmann - 2021 - pesquisa.bvsalud.org
The emergence of SARS-CoV-2 variants threatens efforts to contain the COVID-19 pandemic.
The number of COVID-19 cases and deaths in India has risen steeply in recent weeks and …
The number of COVID-19 cases and deaths in India has risen steeply in recent weeks and …
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization (preprint)
…, MS Winkler, S Schulz, HM Jaeck, S Poehlmann - 2021 - pesquisa.bvsalud.org
Transmission of SARS-CoV-2 from humans to farmed mink was observed in Europe and the
US. In the infected animals viral variants arose that harbored mutations in the spike (S) …
US. In the infected animals viral variants arose that harbored mutations in the spike (S) …
TMPRSS2 is essential for SARS-CoV-2 Beta and Omicron infection (preprint)
…, D Bruder, M Widera, S Ciesek, S Poehlmann… - 2022 - pesquisa.bvsalud.org
The COVID-19 pandemic remains a global health threat and novel antiviral strategies are
urgently needed. SARS-CoV-2 employs the cellular serine protease TMPRSS2 for entry into …
urgently needed. SARS-CoV-2 employs the cellular serine protease TMPRSS2 for entry into …
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants (preprint)
…, SR Isaacs, V Mathivanan, M Hoffman, S Poehlmann… - 2020 - pesquisa.bvsalud.org
The SARS-CoV-2 antibody neutralization response and its evasion by emerging viral variants
are unknown. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants…
are unknown. Antibody immunoreactivity against SARS-CoV-2 antigens and Spike variants…
Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent
A Hansch, S Betge, G Poehlmann, S Neumann… - European …, 2011 - Springer
Objective Agreement rate between magnetic resonance imaging (MRI) and Doppler
ultrasound (DUS) for the detection of deep vein thrombosis (DVT) in the lower extremities was …
ultrasound (DUS) for the detection of deep vein thrombosis (DVT) in the lower extremities was …